Johnson & Johnson
JNJ
#9
Rank
$463.62 B
Marketcap
$177.33
Share price
0.05%
Change (1 day)
11.39%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

P/E ratio for Johnson & Johnson (JNJ)

P/E ratio as of November 2022 (TTM): 24.4

According to Johnson & Johnson's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 24.3515. At the end of 2021 the company had a P/E ratio of 21.6.

P/E ratio history for Johnson & Johnson from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
202121.6-23.35%
202028.233.07%
201921.2-6.74%
201822.7-92.46%
20173011460.23%
201619.34.46%
201518.52.49%
201418.0-3.32%
201318.64.62%
201217.8

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
8.96-63.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
9.34-61.66%๐Ÿ‡บ๐Ÿ‡ธ USA
21.8-10.35%๐Ÿ‡บ๐Ÿ‡ธ USA
19.6-19.43%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
56.4 131.73%๐Ÿ‡บ๐Ÿ‡ธ USA
13.8-43.28%๐Ÿ‡ซ๐Ÿ‡ท France
32.0 31.55%๐Ÿ‡บ๐Ÿ‡ธ USA
35.0 43.58%๐Ÿ‡บ๐Ÿ‡ธ USA
18.0-26.14%๐Ÿ‡บ๐Ÿ‡ธ USA
4.27-82.47%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.